Table 3.

Univariate linear regression analysis with FCR as the dependent variable

	Unstd. B (95% CI)1	Std β	p value	R2
Gender2	− 0.54 (− 0.82; − 0.26)	− 0.12	0.00	0.02
Age at survey	− 0.03 (− 0.04; − 0.01)	− 0.11	0.00	0.01
Education. > 13 years	0.19 (− 0.07; 0.44)	0.05	0.16	0.00
Living alone	− 0.23 (− 0.61; 0.16)	− 0.04	0.24	0.00
Living with children	0.42 (0.17; 0.67)	0.11	0.00	0.01
Diagnostic group3				0.03
BC	0.39 (0.19; 0.6)	0.17	0.00
CRC	0.07 (− 0.13; 0.28)	0.03	0.48
NHL	0.15 (− 0.06; 0.36)	0.06	0.15
LEU	− 0.14 (− 0.35; 0.06)	− 0.05	0.18
Time since diagnosis	− 0.04 (− 0.06; − 0.02)	− 0.14	0.00	0.02
Age at first diagnosis	0 (− 0.02; 0.03)	0.01	0.87	0.00
Treatment4				0.01
Local treatment	− 0.47 (− 0.93; − 0.02)	− 0.08	0.04
Systemic treatment alone	− 0.26 (− 0.71; 0.19)	− 0.04	0.26
Systemic treatments + surgery and/or RT	0.13 (− 0.18; 0.44)	0.03	0.41
Somatic co-morbidity				0.00
1–2 co-morbid somatic conditions	0.24 (− 0.05; 0.54)	0.06	0.10
> 2 co-morbid somatic conditions	0.12 (− 0.25; 0.49)	0.02	0.52
Pain interfering with normal work	0.99 (0.57; 1.4)	0.15	0.00	0.02
Trouble sleeping	0.7 (0.45; 0.95)	0.18	0.00	0.03
Late effects	0.65 (0.4; 0.9)	0.16	0.00	0.03
Anxiety	0.24 (0.21; 0.27)	0.45	0.00	0.20
Fatigue	0.11 (0.08; 0.13)	0.26	0.00	0.07
Depression	0.15 (0.12; 0.17)	0.35	0.00	0.13
PTSS	0.24 (0.22; 0.25)	0.62	0.00	0.38

¹Confidence interval

²Ref.: female

³Ref.: MM

⁴Ref.: limited surgery